UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-07, Vol.373 (2), p.123-135

2015

Volltextzugriff (PDF)

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Scientific reports, 2024-06, Vol.14 (1), p.13765-12

2024

Volltextzugriff (PDF)

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

Scientific reports, 2020-10, Vol.10 (1), p.18677, Article 18677

2020

Volltextzugriff (PDF)

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

The Journal of nuclear medicine (1978), 2023-10, Vol.64 (10), p.1540-1549

2023

Volltextzugriff (PDF)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Radiation oncology (London, England), 2021-09, Vol.16 (1), p.1-176, Article 176

2021

Volltextzugriff (PDF)

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

Frontiers in immunology, 2013-01, Vol.4, p.33-33

2013

Volltextzugriff (PDF)

Multimodal treatment of non-small-cell lung cancer

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1018-1020

2015

Volltextzugriff (PDF)

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2010-06, Vol.139 (6), p.1424-1430

2010

Volltextzugriff (PDF)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

Journal of Nuclear Medicine, 2021-12, Vol.62 (12), p.1684-1691

2021

Volltextzugriff (PDF)

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

Biochemical and biophysical research communications, 2018-06, Vol.500 (3), p.621-625

2018

Volltextzugriff (PDF)

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

Theranostics, 2024-08, Vol.14 (14), p.5400-5412

2024

Volltextzugriff (PDF)

Clinical implications of the innovations in the primary tumour and metastasis of the 8th edition of the TNM classification for lung cancer

Journal of thoracic disease, 2018-08, Vol.10 (S22), p.S2682-S2685

2018

Volltextzugriff (PDF)

Surgery in stage III non-small-cell lung cancer

The Lancet (British edition), 2009-08, Vol.374 (9687), p.359-360

2009

Volltextzugriff (PDF)

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations

Clinical lung cancer, 2021-09, Vol.22 (5), p.e668-e672

2021

Volltextzugriff (PDF)

Konzepte beim oligometastasierten Lungenkarzinom

Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift, 2023-11, Vol.26 (5-6), p.202-211

2023

Volltextzugriff (PDF)

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms

Die Innere Medizin, 2022-07, Vol.63 (7), p.717-723

2022

Volltextzugriff (PDF)

Treatment of early and locally advanced stages of non-small cell lung cancer

Innere Medizin (Heidelberg, Germany), 2022-07, Vol.63 (7), p.717-723

2022

Volltextzugriff (PDF)

Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Journal of Nuclear Medicine, 2024-08, Vol.65 (8), p.1188-1193

2024

Volltextzugriff (PDF)

68 Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

Journal of Nuclear Medicine, 2023-10, Vol.64 (10), p.1540-1549

2023

Volltextzugriff (PDF)

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

The European respiratory journal, 2023-02, Vol.61 (2), p.2201336

2023

Volltextzugriff (PDF)

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors

Immunotherapy, 2022-08, Vol.14 (12), p.927-944

2022

Volltextzugriff (PDF)

Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms

Oncotarget, 2018-10, Vol.9 (80), p.35181-35194

2018

Volltextzugriff (PDF)

Clinical implications of the innovations in the primary tumour and metastasis of the 8 th edition of the TNM classification for lung cancer

Journal of thoracic disease, 2018-08, Vol.10 (Suppl 22), p.S2682

2018

Volltextzugriff (PDF)

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

Oncotarget, 2018-04, Vol.9 (32), p.22254-22268

2018

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(15)
Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Lung Neoplasms - Pathology
(10)
Female
(9)
Male
(9)
Aged
(8)
Carcinoma, Non-Small-Cell Lung - Pathology
(8)
Lung Cancer
(8)
Middle Aged
(8)
Adult
(7)
Aged, 80 And Over
(6)
Biological And Medical Sciences
(6)
Lung Neoplasms - Drug Therapy
(6)
Lung Neoplasms - Mortality
(6)
Medical Sciences
(6)
Neoplasm Staging
(6)
Pneumology
(6)
Radiation Therapy
(6)
Tumors Of The Respiratory System And Mediastinum
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

Multimodal treatment of non-small-cell lung cancer

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

Clinical implications of the innovations in the primary tumour and metastasis of the 8th edition of the TNM classification for lung cancer

Surgery in stage III non-small-cell lung cancer

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68 Ga-SSO120 PET with immunohistochemistry and survival

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations

Konzepte beim oligometastasierten Lungenkarzinom

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms

Treatment of early and locally advanced stages of non-small cell lung cancer

Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

68 Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors

Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms

Clinical implications of the innovations in the primary tumour and metastasis of the 8 th edition of the TNM classification for lung cancer

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

Aktive Filter

Suchergebnisse filtern